NCT01542476View on ClinicalTrials.gov

The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction

CompletedOBSERVATIONAL
Enrollment

299

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Prescribed by the physician solely as a result of a normal clinical evaluation. The physician determines the starting dose and frequency, as well as later changes to either dose or frequency, if any

Trial Locations (1)

Unknown

Alphen aan den Rijn

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY